Correction to: Autoimmune Cerebellar Ataxia Associated with Anti-Glutamate Receptor δ2 Antibodies: a Rare but Treatable Entity

Cerebellum. 2024 Feb;23(1):267. doi: 10.1007/s12311-023-01541-5.

Laura Khatib¹, Le-Duy Do^{1

2}, Marie Benaiteau¹, Macarena Villagrán-García^{1

2}, Madeleine Scharf³, Pierre Meyer^{4

5}, Lydia Abou Haidar⁴, Sophie Demeret⁶, Jérôme Honnorat^{7

8}

¹ French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 59 Boulevard Pinel, Bron Cedex, 69677, Lyon, France.
² MeLiS-UCBL-CNRS UMR 5284-INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France.
³ Institute of Experimental Immunology, affiliated to EURIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany.
⁴ Pediatric Neurology Department, CHU de Montpellier, Montpellier, France.
⁵ Phymedexp, CNRS, INSERM, Université de Montpellier, Montpellier, France.
⁶ Neurology departement, CHU Pitie Salpetrière, Paris, France.
⁷ French Reference Center for Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, 59 Boulevard Pinel, Bron Cedex, 69677, Lyon, France. [email protected].
⁸ MeLiS-UCBL-CNRS UMR 5284-INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France. [email protected].

No abstract available

Publication types